WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹2,043 Cr | ₹2,791 Cr | ₹3,435 Cr | ₹3,207 Cr | ₹3,121 Cr |
What is the latest Total Current Liabilities ratio of WOCKHARDT ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹2,043 Cr |
Mar2024 | ₹2,791 Cr |
Mar2023 | ₹3,435 Cr |
Mar2022 | ₹3,207 Cr |
Mar2021 | ₹3,121 Cr |
How is Total Current Liabilities of WOCKHARDT Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹2,043 Cr | -26.80 | |
Mar2024 | ₹2,791 Cr | -18.75 | |
Mar2023 | ₹3,435 Cr | 7.11 | |
Mar2022 | ₹3,207 Cr | 2.76 | |
Mar2021 | ₹3,121 Cr | - |
Compare Total Current Liabilities of peers of WOCKHARDT
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WOCKHARDT | ₹21,848.9 Cr | -3.2% | -13.2% | 25.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,872.0 Cr | 0.6% | 3.6% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,706.0 Cr | 1% | 9.4% | 8% | Stock Analytics | |
CIPLA | ₹127,449.0 Cr | 0.9% | 1.2% | -0.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,125.0 Cr | 1.7% | 1% | 1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,827.0 Cr | -0.5% | -4.2% | -6.3% | Stock Analytics |
WOCKHARDT Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WOCKHARDT | -3.2% |
-13.2% |
25.6% |
SENSEX | 1.8% |
1.9% |
2.4% |
You may also like the below Video Courses